Cancer Immunotherapy: Priming the Host Immune Response with Live Attenuated Salmonella enterica

In recent years, cancer immunotherapy has undergone great advances because of our understanding of the immune response and the mechanisms through which tumor cells evade it. A century after the first immunotherapy attempt based on bacterial products described by William Coley, the use of live attenu...

Full description

Saved in:
Bibliographic Details
Main Authors: Marco Antonio Hernández-Luna, Rosendo Luria-Pérez
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2018/2984247
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850166425388318720
author Marco Antonio Hernández-Luna
Rosendo Luria-Pérez
author_facet Marco Antonio Hernández-Luna
Rosendo Luria-Pérez
author_sort Marco Antonio Hernández-Luna
collection DOAJ
description In recent years, cancer immunotherapy has undergone great advances because of our understanding of the immune response and the mechanisms through which tumor cells evade it. A century after the first immunotherapy attempt based on bacterial products described by William Coley, the use of live attenuated bacterial vectors has become a promising alternative in the fight against cancer. This review describes the role of live attenuated Salmonella enterica as an oncolytic and immunotherapeutic agent, due to its high affinity for tumor tissue and its ability to activate innate and adaptive antitumor immune response. Furthermore, its potential use as delivery system of tumor antigens and immunomodulatory molecules that induce tumor regression is also reviewed.
format Article
id doaj-art-e11f16495ce34ea99d2f4dd9403065b9
institution OA Journals
issn 2314-8861
2314-7156
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-e11f16495ce34ea99d2f4dd9403065b92025-08-20T02:21:28ZengWileyJournal of Immunology Research2314-88612314-71562018-01-01201810.1155/2018/29842472984247Cancer Immunotherapy: Priming the Host Immune Response with Live Attenuated Salmonella entericaMarco Antonio Hernández-Luna0Rosendo Luria-Pérez1Department of Medicine and Nutrition, University of Guanajuato, Campus Leon, Leon, GTO, MexicoUnit of Investigative Research on Oncological Diseases, Children's Hospital of Mexico Federico Gomez, Mexico City, MexicoIn recent years, cancer immunotherapy has undergone great advances because of our understanding of the immune response and the mechanisms through which tumor cells evade it. A century after the first immunotherapy attempt based on bacterial products described by William Coley, the use of live attenuated bacterial vectors has become a promising alternative in the fight against cancer. This review describes the role of live attenuated Salmonella enterica as an oncolytic and immunotherapeutic agent, due to its high affinity for tumor tissue and its ability to activate innate and adaptive antitumor immune response. Furthermore, its potential use as delivery system of tumor antigens and immunomodulatory molecules that induce tumor regression is also reviewed.http://dx.doi.org/10.1155/2018/2984247
spellingShingle Marco Antonio Hernández-Luna
Rosendo Luria-Pérez
Cancer Immunotherapy: Priming the Host Immune Response with Live Attenuated Salmonella enterica
Journal of Immunology Research
title Cancer Immunotherapy: Priming the Host Immune Response with Live Attenuated Salmonella enterica
title_full Cancer Immunotherapy: Priming the Host Immune Response with Live Attenuated Salmonella enterica
title_fullStr Cancer Immunotherapy: Priming the Host Immune Response with Live Attenuated Salmonella enterica
title_full_unstemmed Cancer Immunotherapy: Priming the Host Immune Response with Live Attenuated Salmonella enterica
title_short Cancer Immunotherapy: Priming the Host Immune Response with Live Attenuated Salmonella enterica
title_sort cancer immunotherapy priming the host immune response with live attenuated salmonella enterica
url http://dx.doi.org/10.1155/2018/2984247
work_keys_str_mv AT marcoantoniohernandezluna cancerimmunotherapyprimingthehostimmuneresponsewithliveattenuatedsalmonellaenterica
AT rosendoluriaperez cancerimmunotherapyprimingthehostimmuneresponsewithliveattenuatedsalmonellaenterica